Amneal Pharmaceuticals, Inc. (AMRX): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

324.81M
Year ended 2025-12-31
+29.1%
3-year compound annual growth
+16.9%
5-year compound annual growth
2018-12-31: 127.25M2019-12-31: 132.11M2020-12-31: 148.91M2021-12-31: 151.82M2022-12-31: 150.94M2023-12-31: 176.14M2024-12-31: 308.98M2025-12-31: 324.81M324.81M
2018-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-31324.81M+5.1%2026-02-27, From 2025-01-01
2024-12-31308.98M+75.4%2026-02-27, From 2024-01-01
2023-12-31176.14M+16.7%2026-02-27, From 2023-01-01
2022-12-31150.94M-0.6%2025-02-28, From 2022-01-01
2021-12-31151.82M+2.0%2024-03-14, From 2021-01-01
2020-12-31148.91M+12.7%2023-03-03, From 2020-01-01
2019-12-31132.11M+3.8%2022-03-01, From 2019-01-01
2018-12-31127.25Mn/a2021-03-01, From 2018-01-01